What is CGNH stock price today?

CGNH (CardioGenics Holdings Inc) stock is trading at $0.00 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is CGNH stock going up or down today?

CGNH stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy CGNH stock now?

The decision to buy CGNH depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is CGNH a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for CGNH based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is CGNH stock overvalued or undervalued?

Use our DCF valuation calculator to determine if CGNH is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is CGNH's P/E ratio?

P/E ratio data for CGNH will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is CGNH's market cap?

CGNH (CardioGenics Holdings Inc) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is CGNH's price to book ratio?

Price-to-book ratio for CGNH is available on our dashboard along with other valuation metrics.

Does CGNH pay dividends?

CGNH does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is CGNH's dividend yield?

CGNH does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is CGNH stock a good long-term investment?

CGNH's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is CGNH's revenue growth rate?

Revenue growth data for CGNH is available on our dashboard with detailed financial statement analysis.

Profitability metrics for CGNH are available on our dashboard with complete income statement analysis.

What are the risks of investing in CGNH?

Key risks for CGNH include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does CGNH compare to its competitors?

Compare CGNH to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize CGNH's performance and positioning.

What is CGNH's stock price target for 2026?

Our AI model provides price targets for CGNH based on fundamental analysis: Bull case $0.00 (+30%), Base case $0.00 (+15%), Bear case $0.00 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about CGNH?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for CGNH. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is CGNH's next earnings report?

CGNH reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

CGNH - CardioGenics Holdings Inc

NYSE * Healthcare * Diagnostics & Research

$0.00

+$0.00 (+0.00%)

About CardioGenics Holdings Inc

CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market. Its products include QL Care Analyzer, which is a portable, stand-alone, and automated POC immunoanalyzer; a series of immunoassay tests to enhance the management of patients with cardiovascular diseases; and paramagnetic beads that are used as a solid surface in medical laboratories' immunoassay testing equipment. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was incorporated in 1997 and is based in Mississauga, Canada.

CGNH Key Statistics

Market Cap

$0.01M

000

Employees

How CGNH Compares to Peers

CGNH is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
CGNH(This stock)	$9.61K	N/A	0%	0.0%	-
UNHUnitedhealth Group	$285.06B	23.8	0%	0.0%	vs UNH
JNJJohnson &	$565.22B	21.3	0%	0.2%	vs JNJ
LLYEli Lilly	$809.09B	39.3	0%	0.3%	vs LLY
PFEPfizer Inc	$154.84B	20.0	-0%	0.1%	vs PFE
ABBVAbbvie Inc	$369.65B	88.6	0%	0.1%	vs ABBV

CardioGenics Holdings Inc Company Information

Headquarters: 6295 Northam Drive, Mississauga, ON, Canada, L4V 1W8, undefined
Website: www.cardiogenics.com
Sector: Healthcare
Industry: Diagnostics & Research

Data Updated: April 17, 2026 at 9:53 PM EDT

Ready to invest in CGNH?

Commission-free trading available. Affiliate links.

Upcoming Events for CGNH

Dashboard

Enter a ticker to analyze